NEUPATH HEALTH INC (NPTH.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:NPTH - CA64133P1009 - Common Stock
0.52 CAD
+0.01 (+1.96%)
We assign a fundamental rating of 3 out of 10 to NPTH. NPTH was compared to 14 industry peers in the Health Care Providers & Services industry. NPTH scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NPTH is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
NPTH had negative earnings in the past year.
NPTH had a positive operating cash flow in the past year.
In the past 5 years NPTH always reported negative net income.
NPTH had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
NPTH has a Return On Assets (-1.20%) which is comparable to the rest of the industry.
NPTH's Return On Equity of -2.63% is in line compared to the rest of the industry. NPTH outperforms 57.14% of its industry peers.
NPTH has a better Return On Invested Capital (5.06%) than 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.2% | ||
| ROE | -2.63% | ||
| ROIC | 5.06% |
ROA(3y)-3.74%
ROA(5y)-5.69%
ROE(3y)-7.64%
ROE(5y)-10.74%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NPTH has a Operating Margin of 2.76%. This is comparable to the rest of the industry: NPTH outperforms 57.14% of its industry peers.
NPTH has a Gross Margin of 19.25%. This is in the lower half of the industry: NPTH underperforms 64.29% of its industry peers.
NPTH's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.76% | ||
| PM (TTM) | N/A | ||
| GM | 19.25% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y-1.04%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NPTH is destroying value.
The number of shares outstanding for NPTH remains at a similar level compared to 1 year ago.
NPTH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NPTH has been reduced compared to a year ago.
2.2 Solvency
NPTH has an Altman-Z score of 1.91. This is not the best score and indicates that NPTH is in the grey zone with still only limited risk for bankruptcy at the moment.
NPTH's Altman-Z score of 1.91 is fine compared to the rest of the industry. NPTH outperforms 78.57% of its industry peers.
The Debt to FCF ratio of NPTH is 4.69, which is a neutral value as it means it would take NPTH, 4.69 years of fcf income to pay off all of its debts.
NPTH's Debt to FCF ratio of 4.69 is fine compared to the rest of the industry. NPTH outperforms 71.43% of its industry peers.
A Debt/Equity ratio of 0.56 indicates that NPTH is somewhat dependend on debt financing.
The Debt to Equity ratio of NPTH (0.56) is better than 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 4.69 | ||
| Altman-Z | 1.91 |
ROIC/WACC0.72
WACC7.04%
2.3 Liquidity
A Current Ratio of 1.12 indicates that NPTH should not have too much problems paying its short term obligations.
The Current ratio of NPTH (1.12) is better than 92.86% of its industry peers.
A Quick Ratio of 1.12 indicates that NPTH should not have too much problems paying its short term obligations.
The Quick ratio of NPTH (1.12) is better than 92.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
NPTH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.21%, which is quite impressive.
Looking at the last year, NPTH shows a quite strong growth in Revenue. The Revenue has grown by 18.67% in the last year.
Measured over the past years, NPTH shows a small growth in Revenue. The Revenue has been growing by 7.96% on average per year.
EPS 1Y (TTM)34.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.97%
Revenue 1Y (TTM)18.67%
Revenue growth 3Y6.16%
Revenue growth 5Y7.96%
Sales Q2Q%25.79%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.77%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for NPTH. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
92.86% of the companies in the same industry are more expensive than NPTH, based on the Enterprise Value to EBITDA ratio.
NPTH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NPTH is cheaper than 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.18 | ||
| EV/EBITDA | 8.21 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for NPTH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX-V:NPTH (12/19/2025, 7:00:00 PM)
0.52
+0.01 (+1.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners25.01%
Inst Owner ChangeN/A
Ins Owners2.31%
Ins Owner ChangeN/A
Market Cap29.20M
Revenue(TTM)83.93M
Net Income(TTM)-553.00K
Analysts80
Price Target0.51 (-1.92%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)15.78%
Min Revenue beat(2)10.97%
Max Revenue beat(2)20.6%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)-100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)17.5%
Revenue NY rev (1m)7.14%
Revenue NY rev (3m)7.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.35 | ||
| P/FCF | 10.18 | ||
| P/OCF | 7.77 | ||
| P/B | 1.39 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.21 |
EPS(TTM)-0.01
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)0.05
FCFY9.83%
OCF(TTM)0.07
OCFY12.87%
SpS1.49
BVpS0.37
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.2% | ||
| ROE | -2.63% | ||
| ROCE | 7.03% | ||
| ROIC | 5.06% | ||
| ROICexc | 5.89% | ||
| ROICexgc | 23.5% | ||
| OM | 2.76% | ||
| PM (TTM) | N/A | ||
| GM | 19.25% | ||
| FCFM | 3.42% |
ROA(3y)-3.74%
ROA(5y)-5.69%
ROE(3y)-7.64%
ROE(5y)-10.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y-1.04%
F-Score6
Asset Turnover1.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 4.69 | ||
| Debt/EBITDA | 2.53 | ||
| Cap/Depr | 38.3% | ||
| Cap/Sales | 1.06% | ||
| Interest Coverage | 7.09 | ||
| Cash Conversion | 81.07% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 1.91 |
F-Score6
WACC7.04%
ROIC/WACC0.72
Cap/Depr(3y)39.19%
Cap/Depr(5y)26.48%
Cap/Sales(3y)1.5%
Cap/Sales(5y)1.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.97%
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.67%
Revenue growth 3Y6.16%
Revenue growth 5Y7.96%
Sales Q2Q%25.79%
Revenue Next Year22.77%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y103.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year308.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.94%
FCF growth 3Y3.23%
FCF growth 5YN/A
OCF growth 1Y20.57%
OCF growth 3Y10.75%
OCF growth 5YN/A
NEUPATH HEALTH INC / NPTH.CA FAQ
Can you provide the ChartMill fundamental rating for NEUPATH HEALTH INC?
ChartMill assigns a fundamental rating of 3 / 10 to NPTH.CA.
What is the valuation status of NEUPATH HEALTH INC (NPTH.CA) stock?
ChartMill assigns a valuation rating of 2 / 10 to NEUPATH HEALTH INC (NPTH.CA). This can be considered as Overvalued.
What is the profitability of NPTH stock?
NEUPATH HEALTH INC (NPTH.CA) has a profitability rating of 3 / 10.